GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (STU:63E) » Definitions » EV-to-Revenue

Onward Medical NV (STU:63E) EV-to-Revenue : (As of Jun. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Onward Medical NV's enterprise value is €163.02 Mil. Onward Medical NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil. Therefore, Onward Medical NV's EV-to-Revenue for today is .

The historical rank and industry rank for Onward Medical NV's EV-to-Revenue or its related term are showing as below:

STU:63E's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.93
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-13), Onward Medical NV's stock price is €5.24. Onward Medical NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Therefore, Onward Medical NV's PS Ratio for today is .


Onward Medical NV EV-to-Revenue Historical Data

The historical data trend for Onward Medical NV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV EV-to-Revenue Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - - -

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Onward Medical NV's EV-to-Revenue

For the Biotechnology subindustry, Onward Medical NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's EV-to-Revenue falls into.



Onward Medical NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Onward Medical NV's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=163.020/0
=

Onward Medical NV's current Enterprise Value is €163.02 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (STU:63E) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Onward Medical NV's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5.24/0
=

Onward Medical NV's share price for today is €5.24.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (STU:63E) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (STU:63E) Headlines

No Headlines